Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.

Abstract

We aimed to analyze the risk of non-cancer mortality according to duration of antipsychotic use and to compare the risk associated with polypharmacy and monotherapy among community-dwellers with Alzheimer's disease (AD). The risk of mortality between most frequently used antipsychotic drugs was compared. Data from a nationwide register-based MEDALZ study… (More)
DOI: 10.3233/JAD-160671

Topics

Cite this paper

@article{Koponen2017RiskOM, title={Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.}, author={Marjaana Koponen and Heidi Taipale and Piia T Lavikainen and Antti Tanskanen and Jari Tiihonen and Anna-Maija Tolppanen and Riitta Ahonen and Sirpa Hartikainen}, journal={Journal of Alzheimer's disease : JAD}, year={2017}, volume={56 1}, pages={107-118} }